Bio-Rad Laboratories | BIO - Market Capitalization

Stock Price
246.42
Daily Change
2.91 1.20%
Monthly
-16.74%
Yearly
1.42%
Q2 Forecast
249.06

Bio-Rad Laboratories reported $5.64B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
Agilent USD 37.86B 3.64B Dec/2025
Becton, Dickinson and Co. USD 44.45B 323M May/2026
Bio Techne USD 7.45B 723M May/2026
Bruker USD 6.41B 915M May/2026
Charles River Laboratories USD 9.29B 1.44B May/2026
Danaher USD 128.46B 33.24B Mar/2026
General Electric Aerospace USD 296.49B 28.42B Mar/2026
Illumina USD 17.88B 2.74B Mar/2026
IQVIA Holdings USD 31.35B 2.72B May/2026
Laboratory Of America USD 21.93B 1.13B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Mettler Toledo International USD 28.34B 2.8B May/2026
Myriad Genetics USD 575M 98M Dec/2025
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Quest Diagnostics USD 21.69B 2.39B Mar/2026
Repligen USD 7.01B 360M May/2026
Revvity USD 11.4B 1.46B May/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Siemens EUR 217.31B 56.45B May/2026
Standard Biotools USD 492M 5M Dec/2025
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
Tosoh JPY 833.86B 81.79B May/2026
Waters USD 21.02B 8.84B May/2026